CNR1 and neurodegenerative disease: A large number of reports point to the involvement of ECs and their lipid analogues in regulating ROS/RNS and reactive aldehydes generation through targeting CB1 and CB2 [8,9,10] and thereby exerting protective effects in cardiovascular as well as renal, hepatic, neuropsychiatric, and neurodegenerative diseases.